Recently, some papers reported that in chronic lymphocytic leukemia (CLL) patients, CD39-expressing nonmalignant T lymphocytes are increased compared with in normal control, and the higher expression levels of CD39 are associated with the worse prognosis of the disease [16, 36]. Here, ENTPD1 is linked to B-cell chronic lymphocytic leukemia.